Literature DB >> 11368258

Effect of metronidazole on the growth of vaginal lactobacilli in vitro.

J A Simoes1, A A Aroutcheva, S Shott, S Faro.   

Abstract

OBJECTIVE: To determine whether metronidazole has an adverse effect on the growth of Lactobacillus.
METHODS: Hydrogen peroxide- and bacteriocin-producing strains of Lactobacillus were used as test strains. Concentrations of metronidazole used ranged from 128 to 7000 microg/ml. Susceptibility to metronidazole was conducted by the broth microdilution method recommended by the National Committee for Clinical Laboratory Standards.
RESULTS: Growth of Lactobacillus was partially inhibited at concentrations between 1000 and 4000 microg/ml (p = 0.014). Concentrations > or = 5000 microg/ml completely inhibited growth of Lactobacillus. Concentrations between 128 and 256 microg/ml stimulated growth of Lactobacillus (p = 0.025 and 0.005, respectively). Concentrations of metronidazole between 64 and 128 microg/ml or > or = 512 microg/ml did not have an inhibitory or a stimulatory effect on the growth of Lactobacillus compared to the control.
CONCLUSIONS: High concentration of metronidazole, i.e. between 1000 and 4000 microg/ml, partially inhibited the growth of Lactobacillus. Concentrations > or = 5000 microg/ml completely suppressed the growth of Lactobacillus. Concentrations between > or = 128 and < or = 256 microg/ml stimulated the growth of Lactobacillus. Further investigation to determine the ideal concentration of metronidazole is needed in order to use the antimicrobial agent effectively in the treatment of bacterial vaginosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11368258      PMCID: PMC1784636          DOI: 10.1155/S1064744901000072

Source DB:  PubMed          Journal:  Infect Dis Obstet Gynecol        ISSN: 1064-7449


  11 in total

1.  Vaginal clindamycin and oral metronidazole for bacterial vaginosis: a randomized trial.

Authors:  J Paavonen; C Mangioni; M A Martin; C P Wajszczuk
Journal:  Obstet Gynecol       Date:  2000-08       Impact factor: 7.661

2.  Long-term follow-up of patients with bacterial vaginosis treated with oral metronidazole and topical clindamycin.

Authors:  J D Sobel; C Schmitt; C Meriwether
Journal:  J Infect Dis       Date:  1993-03       Impact factor: 5.226

3.  Analysis of metronidazole penetration into vaginal fluid by reversed-phase high-performance liquid chromatography.

Authors:  B Davis; D D Glover; B Larsen
Journal:  Am J Obstet Gynecol       Date:  1984-08-01       Impact factor: 8.661

4.  Susceptibility of 40 lactobacilli to six antimicrobial agents with broad gram-positive anaerobic spectra.

Authors:  A S Bayer; A W Chow; N Concepcion; L B Guze
Journal:  Antimicrob Agents Chemother       Date:  1978-11       Impact factor: 5.191

5.  Bacterial vaginosis: sequelae and management.

Authors:  A H Ugwumadu; P Hay
Journal:  Curr Opin Infect Dis       Date:  1999-02       Impact factor: 4.915

6.  Comparison of once-daily and twice-daily dosing of 0.75% metronidazole gel in the treatment of bacterial vaginosis.

Authors:  C H Livengood; D E Soper; K L Sheehan; D E Fenner; M G Martens; A L Nelson; M Ismail; J M Thorp; M Lappin; B J Long; T Blackwelder; R L Sweet; S Sagov
Journal:  Sex Transm Dis       Date:  1999-03       Impact factor: 2.830

7.  Pharmacokinetics of intravaginal metronidazole gel.

Authors:  F E Cunningham; D M Kraus; L Brubaker; J H Fischer
Journal:  J Clin Pharmacol       Date:  1994-11       Impact factor: 3.126

8.  Efficacy of intravaginal 0.75% metronidazole gel for the treatment of bacterial vaginosis.

Authors:  S L Hillier; C Lipinski; A M Briselden; D A Eschenbach
Journal:  Obstet Gynecol       Date:  1993-06       Impact factor: 7.661

9.  The effect of treatment regimens for vaginitis and cervicitis on vaginal colonization by lactobacilli.

Authors:  K J Agnew; S L Hillier
Journal:  Sex Transm Dis       Date:  1995 Sep-Oct       Impact factor: 2.830

10.  Bacterial vaginosis: efficacy and safety of intravaginal metronidazole treatment.

Authors:  C H Livengood; J A McGregor; D E Soper; E Newton; J L Thomason
Journal:  Am J Obstet Gynecol       Date:  1994-03       Impact factor: 8.661

View more
  13 in total

1.  NATURAL ANTIMICROBIALS AND THEIR ROLE IN VAGINAL HEALTH: A SHORT REVIEW.

Authors:  S E Dover; A A Aroutcheva; S Faro; M L Chikindas
Journal:  Int J Probiotics Prebiotics       Date:  2008

2.  A pilot clinical trial comparing an acid-buffering formulation (ACIDFORM gel) with metronidazole gel for the treatment of symptomatic bacterial vaginosis.

Authors:  Jose A Simoes; Luis G Bahamondes; Rodrigo P S Camargo; Valeria M N Alves; Lourens J D Zaneveld; Donald P Waller; Jill Schwartz; Marianne M Callahan; Christine K Mauck
Journal:  Br J Clin Pharmacol       Date:  2006-02       Impact factor: 4.335

3.  Polyethylene glycol-based hydrogels for controlled release of the antimicrobial subtilosin for prophylaxis of bacterial vaginosis.

Authors:  Sujata Sundara Rajan; Veronica L Cavera; Xiaoping Zhang; Yashveer Singh; Michael L Chikindas; Patrick J Sinko
Journal:  Antimicrob Agents Chemother       Date:  2014-02-24       Impact factor: 5.191

4.  Potentiating Metronidazole Scaffold against Resistant Trichomonas: Design, Synthesis, Biology and 3D-QSAR Analysis.

Authors:  Lalit Kumar; Ashish Jain; Nand Lal; Amit Sarswat; Santosh Jangir; Lokesh Kumar; Vishal Singh; Priyanka Shah; Swatantra K Jain; Jagdamba P Maikhuri; Mohammad I Siddiqi; Gopal Gupta; Vishnu L Sharma
Journal:  ACS Med Chem Lett       Date:  2011-12-16       Impact factor: 4.345

5.  Bacterial vaginosis: Etiology and modalities of treatment-A brief note.

Authors:  Nikhil Kumar; Beauty Behera; Sai S Sagiri; Kunal Pal; Sirsendu S Ray; Saroj Roy
Journal:  J Pharm Bioallied Sci       Date:  2011-10

Review 6.  Healthy Vaginal Microbiota and Influence of Probiotics Across the Female Life Span.

Authors:  Liisa Lehtoranta; Reeta Ala-Jaakkola; Arja Laitila; Johanna Maukonen
Journal:  Front Microbiol       Date:  2022-04-08       Impact factor: 6.064

7.  Vaginal colonisation by probiotic lactobacilli and clinical outcome in women conventionally treated for bacterial vaginosis and yeast infection.

Authors:  Sonal Pendharkar; Erik Brandsborg; Lennart Hammarström; Harold Marcotte; Per-Göran Larsson
Journal:  BMC Infect Dis       Date:  2015-07-03       Impact factor: 3.090

8.  Quantitative modeling predicts mechanistic links between pre-treatment microbiome composition and metronidazole efficacy in bacterial vaginosis.

Authors:  Christina Y Lee; Ryan K Cheu; Melissa M Lemke; Andrew T Gustin; Michael T France; Benjamin Hampel; Andrea R Thurman; Gustavo F Doncel; Jacques Ravel; Nichole R Klatt; Kelly B Arnold
Journal:  Nat Commun       Date:  2020-12-01       Impact factor: 14.919

9.  Effects of a 10-Strain Oral Probiotic on Parameters of Vaginal Health and Microbial Community: A Pilot Clinical Study.

Authors:  Christopher J Martoni; Amalie Kruse Sigersted Frederiksen; Anders Damholt; Gregory Leyer
Journal:  Int J Womens Health       Date:  2022-01-18

10.  Antibiotic susceptibility of potentially probiotic vaginal lactobacilli.

Authors:  Virginia Ocaña; Clara Silva; María Elena Nader-Macías
Journal:  Infect Dis Obstet Gynecol       Date:  2006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.